Missing/wrong data?
Log in to edit
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
scientific article published on 10 December 2019
Author/s
author: Emmanuelle Bompas, Isabelle Ray-Coquard
Work details
Publication date
December 10, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.